ENOV — structural market context
Structural market context from public regulatory and market data, shown with its as-of dates. Descriptive only: nothing on this page is a recommendation, a prediction, or advice to buy or sell any security.
ENOV short interest & days to cover
As of 2026-10-30 (FINRA settlement date)
FINRA consolidated short interest, reported twice a month and published ~2 weeks after each settlement date. % of float uses reported free float.
ENOV fails-to-deliver (FTD)
SEC fails-to-deliver files, published twice a month in half-month batches and with a delay; each row carries its settlement date and age.
What changed
As of the close on Nov 20. Each line shows the earlier value, the later value and their dates.
Change from the Nov 19 close to the Nov 20 close: −2.90%.
0.68× its 20-session average on Nov 20.
Includes pre- and post-market trading.
Short interest 10.6M shares (settlement Oct 30) vs 11.7M (Oct 15).
No new file loaded in this window. Latest file: settlement Oct 30, loaded Nov 11.
Latest file (settlements Oct 15–Oct 30, published Nov 17): 6 days with fails, largest 18K shares on Oct 15.
Previous file (settlements Oct 1–Oct 14, published Nov 3): 2 days with fails, largest 332 shares on Oct 6.
No new file loaded in this window.
None recorded in this window.
None recorded in this window.
ENOV events and their magnitude
ENOV insider buying and selling (Form 4)
Last 12 months, Form 4 codes P and S: 13 purchases · 0 sales · 2 distinct buyers in 30 days
SEC Form 4 filings: purchases and sales reported on Form 4 (transaction codes P and S) only; grants and option exercises excluded. Attributed public records.
ENOV analyst ratings
Rating actions as published by the firms, from public feeds. They are not graded here.
Frequently asked questions
Other companies in the same SEC industry: Orthopedic, Prosthetic & Surgical Appliances & Supplies
Industry: SIC code 3842 as recorded on SEC EDGAR.
ENOV: the full history
Latest rows shown. Full history, market-wide screens, cluster detection and the context journal live in the dashboard.
Not financial advice. Trading involves risk. Descriptive structural context, never a recommendation.